Numares Health Gets €40M Financing from European Investment Bank, Existing Investors
Numares will use €20 million from the EIB for research and development and the complementary €20 million from other investors to commercialize its technology.
The flow cytometry test detects two liver disease biomarkers that can be used to provide information about disease severity.
Almac, AstraZeneca Strike CDx Development Pact
Almac will develop companion diagnostic for use with AstraZeneca pharmaceuticals in a range of therapeutic areas.
Swiss Agency Provides CHF 475K to Versantis to Develop POC Blood Ammonia Test
The company will use the ZHAW School of Engineering to develop a prototype device based on a polymersome ammonia quantification method.
The three-biomarker blood test is being made available for the first time to US hepatologists and other clinicians to assess liver disease due to NASH.
May 13, 2021
Apr 14, 2021
Aug 24, 2020
Fibronostics Raises $8M in Series A Round
Apr 29, 2020
DiscernDx Acquires Luminist Labs
Jun 11, 2019